Being fair to participants in placebo-controlled COVID-19 vaccine trials

Rafael Dal-Ré¹, Walter Orenstein^{2

3}, Arthur L Caplan⁴

Affiliations

¹ Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. rafael.dalre@quironsalud.es.
² Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
³ Emory Vaccine Center, Emory University, Atlanta, GA, USA.
⁴ Division of Medical Ethics, Grossman School of Medicine, NYU Langone Medical Center, New York, NY, USA.

Rafael Dal-Ré et al. Nat Med. 2021 Jun.

. 2021 Jun;27(6):938.

doi: 10.1038/s41591-021-01338-1.

Rafael Dal-Ré¹, Walter Orenstein^{2

3}, Arthur L Caplan⁴

¹ Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. rafael.dalre@quironsalud.es.
² Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
³ Emory Vaccine Center, Emory University, Atlanta, GA, USA.
⁴ Division of Medical Ethics, Grossman School of Medicine, NYU Langone Medical Center, New York, NY, USA.

No abstract available

References

1. World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/337940/WHO-2019-nCoVPol... (18 December 2020).
1. World Medical Association. https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/ (October 2013).
1. Council for International Organizations of Medical Sciences (CIOMS). https://cioms.ch/wp-content/uploads/2017/01/WEB-CIOMS-EthicalGuidelines.pdf (2016).
1. Dal-Ré, R., Orenstein, W. & Caplan, A. Lancet Respir. Med. 9, e30–e31 (2021). - DOI
1. Our World in Data. https://ourworldindata.org/covid-vaccinations (accessed 27 March 2021).